Colchicine 0.5 mg + Usual Care Group for atherosclerosis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 16 Apr 2025: Trial registered, NCT06930885
  2. 12 Jun 2025: Trial started, NCT06930885

The trials

NCT06930885: Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease

State
Under way
Phase
Phase 3
People
7,713 planned
Started
12 Jun 2025
Primary completion
May 2031
Arms
Group 3
Results
None posted
  1. 16 Apr 2025: Trial registered
  2. 12 Jun 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.